Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-18 Purchase | 2021-08-19 5:23 pm | IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President | 20,000 | $13.99 | $279,790 | 20,000 (Direct) | View |
| 2020-06-15 Purchase(A) | 2020-06-15 6:39 pm | ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director | 100,000 | $1.289 | $128,900 | 178,750 (Direct) | View |
| 2020-06-15 Purchase | 2020-06-15 6:01 pm | ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director | 100,000 | $1.289 | $128,900 | 178,750 (Direct) | View |
| 2019-11-20 Purchase | 2019-11-21 06:31 am | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 50,000 | $3.41 | $170,500 | 63,700 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-10-10 Option Award | 2023-12-13 4:19 pm | 2024-10-10 2033-10-10 | ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director | 4,068 | $0 | 14,655 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:07 pm | 2024-06-06 2033-06-06 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 75,000 | $0 | 179,800 (Direct) | View |
| 2023-02-14 Option Award | 2023-02-16 6:19 pm | N/A 2033-02-13 | IMPEL PHARMACEUTICALS INC | IMPL | ADAMS ADRIAN COB, CEO and President | 200,000 | $0 | 200,000 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-15 7:31 pm | 2022-07-15 2032-07-14 | ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director | 46,500 | $0 | 242,750 (Direct) | View |
| 2022-06-08 Option Award | 2022-06-09 4:56 pm | 2023-06-08 2032-06-08 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 33,800 | $0 | 124,900 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 5:01 pm | N/A 2032-01-25 | IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President | 175,000 | $0 | 175,000 (Direct) | View |
| 2021-07-20 Option Award | 2021-07-26 5:58 pm | N/A 2031-07-19 | IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President | 50,000 | $0 | 50,000 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-17 5:32 pm | 2022-06-17 2031-06-16 | ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director | 30,000 | $0 | 216,250 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-03 5:27 pm | 2022-06-02 2031-06-02 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 33,800 | $0 | 111,200 (Direct) | View |
Ownership | 2021-04-22 7:01 pm | N/A 2030-01-22 | IMPEL NEUROPHARMA INC | IMPL | ADAMS ADRIAN COB, CEO and President | 0 | $0 | 795,546 (Direct) | View |
| 2020-06-16 Option Award | 2020-06-16 7:13 pm | 2021-06-16 2030-06-15 | ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director | 22,500 | $0 | 201,250 (Direct) | View |
| 2020-06-05 Option Award | 2020-06-09 4:16 pm | 2021-06-05 2030-06-05 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 33,800 | $0 | 97,500 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-25 7:00 pm | 2019-07-25 2029-06-25 | ACELRX PHARMACEUTICALS INC | ACRX | ADAMS ADRIAN Director | 11,250 | $0 | 86,250 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-10 4:03 pm | 2020-06-06 2029-06-06 | Akebia Therapeutics Inc. | AKBA | ADAMS ADRIAN Director | 33,800 | $0 | 33,800 (Direct) | View |